{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:44:46Z","timestamp":1764510286900},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.leukres.2005.12.014","type":"journal-article","created":{"date-parts":[[2006,2,4]],"date-time":"2006-02-04T10:52:41Z","timestamp":1139050361000},"page":"1113-1118","source":"Crossref","is-referenced-by-count":30,"title":["Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia"],"prefix":"10.1016","volume":"30","author":[{"given":"Geothy","family":"Kochethu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Starczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Fegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2005.12.014_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-0734.2000.00001.x","article-title":"Biology of chronic lymphocytic leukemia","volume":"4","author":"Caligaris-Cappio","year":"2000","journal-title":"Rev Clin Exp Hematol"},{"issue":"6810","key":"10.1016\/j.leukres.2005.12.014_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.leukres.2005.12.014_bib3","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1038\/ncb1201-e277","article-title":"The evolution of diverse biological responses to DNA damage: insights from yeast and p53","volume":"3","author":"Wahl","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.leukres.2005.12.014_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.47.1.285","article-title":"Clinical implications of the p53 gene","volume":"47","author":"Sidransky","year":"1996","journal-title":"Annu Rev Med"},{"issue":"26","key":"10.1016\/j.leukres.2005.12.014_bib5","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.leukres.2005.12.014_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/MCB.7.2.961","article-title":"Primary structure polymorphism at amino acid residue 72 of human p53","volume":"7","author":"Matlashewski","year":"1987","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.leukres.2005.12.014_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000154275","article-title":"p53 polymorphisms and haplotypes in different ethnic groups","volume":"45","author":"Sjalander","year":"1995","journal-title":"Hum Hered"},{"issue":"1","key":"10.1016\/j.leukres.2005.12.014_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.onc.1205015","article-title":"The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells","volume":"21","author":"Baptiste","year":"2002","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.leukres.2005.12.014_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","article-title":"The codon 72 polymorphic variants of p53 have markedly different apoptotic potential","volume":"33","author":"Dumont","year":"2003","journal-title":"Nat Genet"},{"issue":"19","key":"10.1016\/j.leukres.2005.12.014_bib10","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/sj.onc.1207428","article-title":"Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo","volume":"23","author":"Sullivan","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.leukres.2005.12.014_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.11548","article-title":"p53 polymorphic variants at codon 72 exert different effects on cell cycle progression","volume":"108","author":"Pim","year":"2004","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2005.12.014_bib12","first-page":"407","article-title":"Polymorphism of the p53 gene within the codon 72 in lung cancer patients","volume":"48","author":"Biros","year":"2001","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.leukres.2005.12.014_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2005.12.014_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"issue":"2\u20133","key":"10.1016\/j.leukres.2005.12.014_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-5002(00)00188-4","article-title":"Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer","volume":"31","author":"Biros","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.leukres.2005.12.014_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2141.2003.04563.x","article-title":"The P2X7 receptor gene polymorphism 1513 A\u2192C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia","volume":"123","author":"Starczynski","year":"2003","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.leukres.2005.12.014_bib17","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2005.02.192","article-title":"Common polymorphism G(\u2212248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukema once treatment is initiated","volume":"23","author":"Starczynski","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.leukres.2005.12.014_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1535-6108(03)00079-5","article-title":"p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis","volume":"3","author":"Bergamaschi","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.leukres.2005.12.014_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/75586","article-title":"A common polymorphism acts as an intragenic modifier of mutant p53 behaviour","volume":"25","author":"Marin","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.leukres.2005.12.014_bib20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","article-title":"Two polymorphic variants of wild-type p53 differ biochemically and biologically","volume":"19","author":"Thomas","year":"1999","journal-title":"Mol Cell Biol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212606000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T12:21:12Z","timestamp":1547814072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212606000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0145212606000105"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2005.12.014","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}